Loading…

Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy

We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow-CDRy and white-CDRw) of venom with a sample of (CDT) venom and examined their neutralization by antivenom against CDT venom. The venoms were screened for enzymatic and coagulant activities using standard assay...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2025-01, Vol.18 (1), p.54
Main Authors: Demico, Poliana J, Oliveira, Isabele N, Proença-Hirata, Vitória S, Dias, Samuel R, Ghirotti, Hugo A, Silva, Elisangela O, Giometti, Inês C, Pacagnelli, Francis L, Torres-Bonilla, Kristian A, Hyslop, Stephen, Galizio, Nathália C, de Morais-Zani, Karen, Pucca, Manuela B, Rocha, Anderson M, Maciel, Jéssica B, Sartim, Marco A, Monteiro, Wuelton M, Floriano, Rafael S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2413-944191d0fb984214d8e39f6581c6f091e22fa1cd900d01eec331cfcbefd62c1e3
container_end_page
container_issue 1
container_start_page 54
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 18
creator Demico, Poliana J
Oliveira, Isabele N
Proença-Hirata, Vitória S
Dias, Samuel R
Ghirotti, Hugo A
Silva, Elisangela O
Giometti, Inês C
Pacagnelli, Francis L
Torres-Bonilla, Kristian A
Hyslop, Stephen
Galizio, Nathália C
de Morais-Zani, Karen
Pucca, Manuela B
Rocha, Anderson M
Maciel, Jéssica B
Sartim, Marco A
Monteiro, Wuelton M
Floriano, Rafael S
description We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow-CDRy and white-CDRw) of venom with a sample of (CDT) venom and examined their neutralization by antivenom against CDT venom. The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A (PLA ), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA and esterolytic activities at the highest quantity tested, and CDT had greater PLA activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw >> CDRy > CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by and their neutralization by the currently used therapeutic antivenom.
doi_str_mv 10.3390/ph18010054
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_aa3d2587cac24d469b89b188a6d0272c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_aa3d2587cac24d469b89b188a6d0272c</doaj_id><sourcerecordid>3159523895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2413-944191d0fb984214d8e39f6581c6f091e22fa1cd900d01eec331cfcbefd62c1e3</originalsourceid><addsrcrecordid>eNpdks9uEzEQxlcIREvhwgMgS1wQasBje3ftUxVFASpVcCm9Wl7_SRztroO9LgpPwuPiJKW0nDye-c2nTzNTVa8Bf6BU4I_bNXAMGNfsSXUKjLAZJ6x9-iA-qV6ktClECwyeVydU8AYA2tPq9yIMWxXV5G8tmo-q3yWfUHBoWlu0HH_thlLS52gR1Cr3apzOkRoN-mpzDENOuuQimuvS7idvD53XPwO6UdEX-PBfxDCpPidkcvQplSDmmP2g0I0dw3DQm497A_vf0jmvld69rJ451Sf76u49q75_Wl4vvsyuvn2-XMyvZpowoDPBGAgw2HWCMwLMcEuFa2oOunFYgCXEKdBGYGwwWKspBe10Z51piAZLz6rLo64JaiO3sfiKOxmUl4dEiCupYhlBb6VS1JCat8UeYYY1ouOiA85VYzBpiS5aF0etbe4Ga7Qdp6j6R6KPK6Nfy1W4lWUVDRctLQrv7hRi-JFtmuTgk7Z9mbwNOUkKteCYNi0u6Nv_0E3IsWzwSNWEclEX6v2R0jGkFK27dwNY7q9H_rueAr956P8e_Xsu9A8hEsJM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3159523895</pqid></control><display><type>article</type><title>Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Demico, Poliana J ; Oliveira, Isabele N ; Proença-Hirata, Vitória S ; Dias, Samuel R ; Ghirotti, Hugo A ; Silva, Elisangela O ; Giometti, Inês C ; Pacagnelli, Francis L ; Torres-Bonilla, Kristian A ; Hyslop, Stephen ; Galizio, Nathália C ; de Morais-Zani, Karen ; Pucca, Manuela B ; Rocha, Anderson M ; Maciel, Jéssica B ; Sartim, Marco A ; Monteiro, Wuelton M ; Floriano, Rafael S</creator><creatorcontrib>Demico, Poliana J ; Oliveira, Isabele N ; Proença-Hirata, Vitória S ; Dias, Samuel R ; Ghirotti, Hugo A ; Silva, Elisangela O ; Giometti, Inês C ; Pacagnelli, Francis L ; Torres-Bonilla, Kristian A ; Hyslop, Stephen ; Galizio, Nathália C ; de Morais-Zani, Karen ; Pucca, Manuela B ; Rocha, Anderson M ; Maciel, Jéssica B ; Sartim, Marco A ; Monteiro, Wuelton M ; Floriano, Rafael S</creatorcontrib><description>We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow-CDRy and white-CDRw) of venom with a sample of (CDT) venom and examined their neutralization by antivenom against CDT venom. The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A (PLA ), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA and esterolytic activities at the highest quantity tested, and CDT had greater PLA activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw &gt;&gt; CDRy &gt; CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by and their neutralization by the currently used therapeutic antivenom.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph18010054</identifier><identifier>PMID: 39861117</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>coagulant activity ; Crotalus durissus venom ; Edema ; enzymatic activity ; intraspecific variation ; Kidney diseases ; Neurotoxicity ; neutralization by antivenom ; Proteins ; Rhabdomyolysis ; Snakes ; Toxins ; Venom</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2025-01, Vol.18 (1), p.54</ispartof><rights>2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2025 by the authors. 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2413-944191d0fb984214d8e39f6581c6f091e22fa1cd900d01eec331cfcbefd62c1e3</cites><orcidid>0000-0003-4572-3109 ; 0000-0003-0759-5863 ; 0000-0003-2594-7068 ; 0000-0002-0688-9483 ; 0000-0002-0848-1940 ; 0000-0001-5259-5905 ; 0000-0002-7856-9542 ; 0000-0001-6476-7778</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3159523895/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3159523895?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39861117$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demico, Poliana J</creatorcontrib><creatorcontrib>Oliveira, Isabele N</creatorcontrib><creatorcontrib>Proença-Hirata, Vitória S</creatorcontrib><creatorcontrib>Dias, Samuel R</creatorcontrib><creatorcontrib>Ghirotti, Hugo A</creatorcontrib><creatorcontrib>Silva, Elisangela O</creatorcontrib><creatorcontrib>Giometti, Inês C</creatorcontrib><creatorcontrib>Pacagnelli, Francis L</creatorcontrib><creatorcontrib>Torres-Bonilla, Kristian A</creatorcontrib><creatorcontrib>Hyslop, Stephen</creatorcontrib><creatorcontrib>Galizio, Nathália C</creatorcontrib><creatorcontrib>de Morais-Zani, Karen</creatorcontrib><creatorcontrib>Pucca, Manuela B</creatorcontrib><creatorcontrib>Rocha, Anderson M</creatorcontrib><creatorcontrib>Maciel, Jéssica B</creatorcontrib><creatorcontrib>Sartim, Marco A</creatorcontrib><creatorcontrib>Monteiro, Wuelton M</creatorcontrib><creatorcontrib>Floriano, Rafael S</creatorcontrib><title>Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>Pharmaceuticals (Basel)</addtitle><description>We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow-CDRy and white-CDRw) of venom with a sample of (CDT) venom and examined their neutralization by antivenom against CDT venom. The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A (PLA ), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA and esterolytic activities at the highest quantity tested, and CDT had greater PLA activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw &gt;&gt; CDRy &gt; CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by and their neutralization by the currently used therapeutic antivenom.</description><subject>coagulant activity</subject><subject>Crotalus durissus venom</subject><subject>Edema</subject><subject>enzymatic activity</subject><subject>intraspecific variation</subject><subject>Kidney diseases</subject><subject>Neurotoxicity</subject><subject>neutralization by antivenom</subject><subject>Proteins</subject><subject>Rhabdomyolysis</subject><subject>Snakes</subject><subject>Toxins</subject><subject>Venom</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks9uEzEQxlcIREvhwgMgS1wQasBje3ftUxVFASpVcCm9Wl7_SRztroO9LgpPwuPiJKW0nDye-c2nTzNTVa8Bf6BU4I_bNXAMGNfsSXUKjLAZJ6x9-iA-qV6ktClECwyeVydU8AYA2tPq9yIMWxXV5G8tmo-q3yWfUHBoWlu0HH_thlLS52gR1Cr3apzOkRoN-mpzDENOuuQimuvS7idvD53XPwO6UdEX-PBfxDCpPidkcvQplSDmmP2g0I0dw3DQm497A_vf0jmvld69rJ451Sf76u49q75_Wl4vvsyuvn2-XMyvZpowoDPBGAgw2HWCMwLMcEuFa2oOunFYgCXEKdBGYGwwWKspBe10Z51piAZLz6rLo64JaiO3sfiKOxmUl4dEiCupYhlBb6VS1JCat8UeYYY1ouOiA85VYzBpiS5aF0etbe4Ga7Qdp6j6R6KPK6Nfy1W4lWUVDRctLQrv7hRi-JFtmuTgk7Z9mbwNOUkKteCYNi0u6Nv_0E3IsWzwSNWEclEX6v2R0jGkFK27dwNY7q9H_rueAr956P8e_Xsu9A8hEsJM</recordid><startdate>20250106</startdate><enddate>20250106</enddate><creator>Demico, Poliana J</creator><creator>Oliveira, Isabele N</creator><creator>Proença-Hirata, Vitória S</creator><creator>Dias, Samuel R</creator><creator>Ghirotti, Hugo A</creator><creator>Silva, Elisangela O</creator><creator>Giometti, Inês C</creator><creator>Pacagnelli, Francis L</creator><creator>Torres-Bonilla, Kristian A</creator><creator>Hyslop, Stephen</creator><creator>Galizio, Nathália C</creator><creator>de Morais-Zani, Karen</creator><creator>Pucca, Manuela B</creator><creator>Rocha, Anderson M</creator><creator>Maciel, Jéssica B</creator><creator>Sartim, Marco A</creator><creator>Monteiro, Wuelton M</creator><creator>Floriano, Rafael S</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4572-3109</orcidid><orcidid>https://orcid.org/0000-0003-0759-5863</orcidid><orcidid>https://orcid.org/0000-0003-2594-7068</orcidid><orcidid>https://orcid.org/0000-0002-0688-9483</orcidid><orcidid>https://orcid.org/0000-0002-0848-1940</orcidid><orcidid>https://orcid.org/0000-0001-5259-5905</orcidid><orcidid>https://orcid.org/0000-0002-7856-9542</orcidid><orcidid>https://orcid.org/0000-0001-6476-7778</orcidid></search><sort><creationdate>20250106</creationdate><title>Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy</title><author>Demico, Poliana J ; Oliveira, Isabele N ; Proença-Hirata, Vitória S ; Dias, Samuel R ; Ghirotti, Hugo A ; Silva, Elisangela O ; Giometti, Inês C ; Pacagnelli, Francis L ; Torres-Bonilla, Kristian A ; Hyslop, Stephen ; Galizio, Nathália C ; de Morais-Zani, Karen ; Pucca, Manuela B ; Rocha, Anderson M ; Maciel, Jéssica B ; Sartim, Marco A ; Monteiro, Wuelton M ; Floriano, Rafael S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2413-944191d0fb984214d8e39f6581c6f091e22fa1cd900d01eec331cfcbefd62c1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>coagulant activity</topic><topic>Crotalus durissus venom</topic><topic>Edema</topic><topic>enzymatic activity</topic><topic>intraspecific variation</topic><topic>Kidney diseases</topic><topic>Neurotoxicity</topic><topic>neutralization by antivenom</topic><topic>Proteins</topic><topic>Rhabdomyolysis</topic><topic>Snakes</topic><topic>Toxins</topic><topic>Venom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demico, Poliana J</creatorcontrib><creatorcontrib>Oliveira, Isabele N</creatorcontrib><creatorcontrib>Proença-Hirata, Vitória S</creatorcontrib><creatorcontrib>Dias, Samuel R</creatorcontrib><creatorcontrib>Ghirotti, Hugo A</creatorcontrib><creatorcontrib>Silva, Elisangela O</creatorcontrib><creatorcontrib>Giometti, Inês C</creatorcontrib><creatorcontrib>Pacagnelli, Francis L</creatorcontrib><creatorcontrib>Torres-Bonilla, Kristian A</creatorcontrib><creatorcontrib>Hyslop, Stephen</creatorcontrib><creatorcontrib>Galizio, Nathália C</creatorcontrib><creatorcontrib>de Morais-Zani, Karen</creatorcontrib><creatorcontrib>Pucca, Manuela B</creatorcontrib><creatorcontrib>Rocha, Anderson M</creatorcontrib><creatorcontrib>Maciel, Jéssica B</creatorcontrib><creatorcontrib>Sartim, Marco A</creatorcontrib><creatorcontrib>Monteiro, Wuelton M</creatorcontrib><creatorcontrib>Floriano, Rafael S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demico, Poliana J</au><au>Oliveira, Isabele N</au><au>Proença-Hirata, Vitória S</au><au>Dias, Samuel R</au><au>Ghirotti, Hugo A</au><au>Silva, Elisangela O</au><au>Giometti, Inês C</au><au>Pacagnelli, Francis L</au><au>Torres-Bonilla, Kristian A</au><au>Hyslop, Stephen</au><au>Galizio, Nathália C</au><au>de Morais-Zani, Karen</au><au>Pucca, Manuela B</au><au>Rocha, Anderson M</au><au>Maciel, Jéssica B</au><au>Sartim, Marco A</au><au>Monteiro, Wuelton M</au><au>Floriano, Rafael S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2025-01-06</date><risdate>2025</risdate><volume>18</volume><issue>1</issue><spage>54</spage><pages>54-</pages><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow-CDRy and white-CDRw) of venom with a sample of (CDT) venom and examined their neutralization by antivenom against CDT venom. The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A (PLA ), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA and esterolytic activities at the highest quantity tested, and CDT had greater PLA activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw &gt;&gt; CDRy &gt; CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by and their neutralization by the currently used therapeutic antivenom.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39861117</pmid><doi>10.3390/ph18010054</doi><orcidid>https://orcid.org/0000-0003-4572-3109</orcidid><orcidid>https://orcid.org/0000-0003-0759-5863</orcidid><orcidid>https://orcid.org/0000-0003-2594-7068</orcidid><orcidid>https://orcid.org/0000-0002-0688-9483</orcidid><orcidid>https://orcid.org/0000-0002-0848-1940</orcidid><orcidid>https://orcid.org/0000-0001-5259-5905</orcidid><orcidid>https://orcid.org/0000-0002-7856-9542</orcidid><orcidid>https://orcid.org/0000-0001-6476-7778</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2025-01, Vol.18 (1), p.54
issn 1424-8247
1424-8247
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_aa3d2587cac24d469b89b188a6d0272c
source Publicly Available Content (ProQuest); PubMed Central
subjects coagulant activity
Crotalus durissus venom
Edema
enzymatic activity
intraspecific variation
Kidney diseases
Neurotoxicity
neutralization by antivenom
Proteins
Rhabdomyolysis
Snakes
Toxins
Venom
title Comparative Analysis of the Enzymatic, Coagulant, and Neuromuscular Activities of Two Variants of Crotalus durissus ruruima Venom and Antivenom Efficacy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A55%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Analysis%20of%20the%20Enzymatic,%20Coagulant,%20and%20Neuromuscular%20Activities%20of%20Two%20Variants%20of%20Crotalus%20durissus%20ruruima%20Venom%20and%20Antivenom%20Efficacy&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Demico,%20Poliana%20J&rft.date=2025-01-06&rft.volume=18&rft.issue=1&rft.spage=54&rft.pages=54-&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph18010054&rft_dat=%3Cproquest_doaj_%3E3159523895%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2413-944191d0fb984214d8e39f6581c6f091e22fa1cd900d01eec331cfcbefd62c1e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3159523895&rft_id=info:pmid/39861117&rfr_iscdi=true